NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sensible Biotechnologies

Sensible Biotechnologies

Private
BratislavaHealthcare & Life Scienceshttps://www.sensible.bio/

Last Round

Seed

Apr 9, 2024

Est. Valuation

$1.79M

Total Funding Raised

$21.68M

Company Overview

Sensible Biotechnologies is a biotechnology company that develops a cell-based platform for the design, optimization, and manufacturing of messenger RNA (mRNA).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

mRNA manufacturingcell-free synthesisbiomanufacturingmRNA therapeuticssequence optimizationsynthetic biologybiotech infrastructuremRNA vaccinesdrug discoveryAI-driven designRNA foldingbiotech platformsynbiocell-freebiotech foundry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sensible Biotechnologies Comparables

Compare Sensible Biotechnologies with similar companies based on industry and business-model similarity.

Sensible Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NTxBio
81%
Spindle Biotech Inc.
78%
Nutcracker Therapeutics
75%

Sensible Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 9, 2024
SeedDec 1, 2023
Pre SeedApr 6, 2023
AcceleratorAug 31, 2021

Key People

Founding team and executive leadership

Miroslav Gasparek

CEO And Co-Founder

Founding Team

Sensible Biotechnologies Investors

Notable investors and investment history

Sensible Biotechnologies investors
InvestorRounds
Backed VCSeed
Recode Health VenturesPre Seed
Recode Health VenturesPre Seed, Seed
KAYASeed
BlueYard CapitalSeed, Pre Seed
Amino CollectivePre Seed
Onsight VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 12, 2025

    Developing novel process to produce mRNA drugs within living cells.

  • Apr 9, 2024

    $9M raised from Y Combinator and other VCs.

Sensible Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sensible Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sensible Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersBratislava
Employee Range30
Year Founded2021
Last FundingApr 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.